# EDGAR Filing Document

**Accession Number:** 0002046386
**File Stem:** 0001193125-26-086630
**Filing Date:** 2026-3
**Character Count:** 5648
**Document Hash:** ef4b1da37e36e3a28f28046fd2895cc2
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-086630.hdr.sgml**: 20260401

**ACCESSION NUMBER**: 0001193125-26-086630

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260303

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Medline Inc.
- **CENTRAL INDEX KEY:** 0002046386
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 331845288
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 3 LAKES DRIVE
- **CITY:** NORTHFIELD
- **STATE:** IL
- **ZIP:** 60093
- **BUSINESS PHONE:** 847-949-3000

**MAIL ADDRESS:**
- **STREET 1:** 3 LAKES DRIVE
- **CITY:** NORTHFIELD
- **STATE:** IL
- **ZIP:** 60093

**Simpson Thacher & Bartlett LLP** 

900 G STREET, NW

WASHINGTON, D.C. 20001

TELEPHONE: +1-202-636-5500

FACSIMILE: +1-202-636-5502

Direct Dial Number +1-202-636-5804 E-mail Address jbonnie@stblaw.com

<u>VIA EDGAR</u> March 3, 2026

Re: Acceleration Request for Medline Inc.<u> </u>

Registration Statement on Form S-1

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Robert Augustin, Esq.

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, we attach the requests of our client, Medline Inc., and of the underwriters that effectiveness of the above-referenced Registration Statement be accelerated to 4:05 p.m., Washington, D.C. time, on March 4, 2026, or as soon as practicable thereafter.

Call me at (202) 636-5804 with any questions.

Very truly yours,

/s/ Joshua Ford Bonnie

Joshua Ford Bonnie

NEW YORK BEIJING BOSTON BRUSSELS HONG KONG HOUSTON LONDON LOS ANGELES LUXEMBOURG PALO ALTO SAN FRANCISCO SÃO PAULO TOKYO

------

March 3, 2026

<u>VIA EDGAR</u> 

Re: Medline Inc.

Registration Statement on Form S-1

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E. Washington, D.C. 20549

Attention: Robert Augustin, Esq.

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Medline Inc. (the "Company") hereby requests that the effective date of the above-referenced Registration Statement be accelerated so that it may become effective at 4:05 p.m., Washington, D.C. time, on March 4, 2026, or as soon as possible thereafter. In this regard, the Company is aware of its obligations under the Securities Act.

[*Signature Page Follows*]

------

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| MEDLINE INC. | MEDLINE INC. |
| By: | /s/ Alexander M. Liberman |
|  | Name: Alexander M. Liberman |
|  | Title: Chief Legal Officer |

---

------

**Goldman Sachs & Co. LLC** 

200 West Street, New York, New York 10282

**Morgan Stanley & Co. LLC** 

1585 Broadway, New York, New York 10036

**BofA Securities, Inc.** 

One Bryant Park, New York, New York 10036

**J.P. Morgan Securities LLC** 

270 Park Avenue, New York, New York 10017

March 3, 2026

**<u>VIA EDGAR</u>**

Re: Medline Inc.<u> </u>

<u>Registration Statement on Form S-1</u>

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attn: Robert Augustin, Esq.

Ladies and Gentlemen:

In connection with the above-referenced Registration Statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the "Act"), and as representatives of the several underwriters of the proposed public offering of Medline Inc.'s (the "Company") Class A common stock, we wish to advise you that we hereby join the Company's request that the effective date of the above-referenced Registration Statement be accelerated so that it may become effective at 4:05 p.m., Washington, D.C. time, on March 4, 2026 or as soon as possible thereafter or at such later time as the Company or its counsel may request.

Pursuant to Rule 460 under the Act, we, as representatives of the several underwriters, wish to advise you that there will be distributed to each underwriter or dealer, who is reasonably anticipated to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.

We, the undersigned, as representatives of the several underwriters, have complied and will continue to comply, and we have been informed by the participating underwriters that they have complied and will continue to comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

[*Signature Page Follows*]

------

---

| | |
|:---|:---|
| Very truly yours,<br>GOLDMAN SACHS & CO. LLC<br> MORGAN STANLEY & CO. LLC<br> BOFA SECURITIES, INC.<br> J.P. MORGAN SECURITIES LLC<br>As Representatives of the Underwriters | Very truly yours,<br>GOLDMAN SACHS & CO. LLC<br> MORGAN STANLEY & CO. LLC<br> BOFA SECURITIES, INC.<br> J.P. MORGAN SECURITIES LLC<br>As Representatives of the Underwriters |
| By: | GOLDMAN SACHS & CO. LLC |
| By: | /s/ Lyla Bibi Maduri |
|  | Name: Lyla Bibi Maduri |
|  | Title: Managing Director |
| By: | MORGAN STANLEY & CO. LLC |
| By: | /s/ Kalli Dircks |
|  | Name: Kalli Dircks |
|  | Title: Managing Director |
| By: | BOFA SECURITIES, INC. |
| By: | /s/ Justin Walter |
|  | Name: Justin Walter |
|  | Title: Managing Director |
| By: | J.P. MORGAN SECURITIES LLC |
| By: | /s/ Benjamin Burdett |
|  | Name: Benjamin Burdett |
|  | Title: Head of Healthcare ECM |

---